XML 18 R7.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities:    
Net loss $ (49,429) $ (60,599)
Adjustments to reconcile net loss to cash flows provided by (used in) operating activities:    
Depreciation and amortization of property and equipment 12,182 10,131
Amortization of intangible assets 33,785 39,077
Amortization of debt issuance costs and original issue discount 2,102 4,137
Amortization of accumulated other comprehensive gain related to interest rate swap   (8,196)
Stock-based compensation 14,619 12,061
Deferred income taxes 52 (14,614)
Change in fair value of warrant liability (2,811) 292
Change in fair value of preferred stock liability   8,091
Dividends accrued on preferred stock liability   2,743
Payment of dividends accrued on preferred stock liability   (6,686)
Foreign currency exchange losses 1,698 1,357
Changes in operating assets and liabilities:    
Accounts receivable 34,258 18,896
Inventory (382) (1,630)
Other operating assets 822 9,456
Accounts payable (5,017) (7,580)
Accrued expenses and other long-term liabilities (15,880) 1,624
Deferred revenue (3,840) (20,087)
Net cash provided by (used in) operating activities 22,159 (11,527)
Cash flows from investing activities:    
Purchases of property and equipment (23,368) (14,428)
Purchases of software licenses   (462)
Net cash used in investing activities (23,368) (14,890)
Cash flows from financing activities:    
Borrowings under revolving line of credit   44,106
Principal payments on revolving line of credit   (44,106)
Proceeds from issuance of term debt   342,300
Principal payments of term debt (3,938) (236,270)
Payment of debt issuance costs   (5,985)
Payment of preferred stock liability   (56,850)
Proceeds from the exercise of stock options 6 17
Payment of tax obligations related to vested stock awards and units (3,827) (3,035)
Repurchase of common stock (5,731)  
Net cash (used in) provided by financing activities (13,490) 40,177
Effect of exchange rate changes on cash and cash equivalents 987 (297)
Net (decrease) increase in cash and cash equivalents (13,712) 13,463
Cash, cash equivalents and restricted cash, beginning of year 90,479 26,630
Cash, cash equivalents and restricted cash, end of period 76,767 40,093
Supplemental disclosure of cash flow information:    
Interest paid 28,797 22,851
Income taxes paid 9,565 12,807
Income tax refunds received 733 1,294
Supplemental disclosure of non-cash investing activities:    
Capital expenditures incurred, but not yet paid 3,642 3,946
Inventory transfers to property and equipment 1,325 1,297
Supplemental disclosure of non-cash financing activities:    
Warrant liability released to additional paid-in-capital 150  
Fair value of vested restricted and performance-based stock grants $ 12,574 $ 10,454